Foghorn Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Foghorn Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Foghorn Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Foghorn Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $341k | 63k | 5.40 |
| 2025-09-30 | $286k | 59k | 4.89 |
| 2025-06-30 | $334k | 71k | 4.72 |
| 2025-03-31 | $145k | 40k | 3.64 |
| 2024-12-31 | $245k | 52k | 4.75 |
| 2024-09-30 | $371k | 40k | 9.29 |
| 2024-06-30 | $79k | 14k | 5.77 |
| 2024-03-31 | $129k | 19k | 6.70 |
| 2023-12-31 | $212k | 33k | 6.44 |
| 2023-09-30 | $18k | 3.6k | 5.05 |
| 2023-06-30 | $29k | 4.1k | 7.12 |
| 2023-03-31 | $62k | 10k | 6.12 |
| 2022-12-31 | $34k | 5.4k | 6.30 |
| 2022-09-30 | $7.0k | 852 | 8.22 |
| 2022-06-30 | $14k | 1.0k | 13.89 |
| 2022-03-31 | $48k | 3.2k | 15.10 |